Clinton Group’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-203,669
| Closed | -$640K | – | 1175 |
|
|
2016
Q2 | $640K | Buy |
+203,669
| New | +$640K | 0.03% | 594 |
|
|
2016
Q1 | – | Sell |
-338,293
| Closed | -$1.2M | – | 1095 |
|
|
2015
Q4 | $1.2M | Buy |
338,293
+155,051
| +85% | +$549K | 0.1% | 323 |
|
|
2015
Q3 | $922K | Buy |
183,242
+106,150
| +138% | +$534K | 0.09% | 323 |
|
|
2015
Q2 | $496K | Buy |
77,092
+26,560
| +53% | +$171K | 0.07% | 380 |
|
|
2015
Q1 | $355K | Buy |
50,532
+33,540
| +197% | +$236K | 0.09% | 321 |
|
|
2014
Q4 | $131K | Sell |
16,992
-29,965
| -64% | -$231K | 0.04% | 438 |
|
|
2014
Q3 | $351K | Buy |
+46,957
| New | +$351K | 0.14% | 240 |
|